Switch to
More onapp

How to use scorecard? Learn more

Neuland Laboratories Ltd

NEULANDLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹8,573 cr, stock is ranked 521
High RiskStock is 5.46x as volatile as Nifty
7,103.25437.85 (+6.57%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

High

The creamy layer - amongst the top performing stocks

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹8,573 cr, stock is ranked 521
High RiskStock is 5.46x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
27.04
PB RatioPB Ratio
8.62
Dividend YieldDiv. Yield
0.15%
Sector PESector PE
52.23
Sector PBSector PB
5.97
Sector Div YldSctr Div Yld
0.56%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Neuland Laboratories Limited is engaged in manufacturing active pharmaceutical ingredient (API). The Company also provides custom manufacturing solutions (CMS) to develop and manufacture pharmaceutical ingredients and intermediates.

Investor PresentationView older 

Aug 3, 2023

PDF
View Older Presentations

Financial TrendFinancial statements 

20202021202220230.770.950.951.200.020.080.060.16
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 3.23%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Credit Rating 
Announced OnMar 28, 2024

Neuland Laboratories Limited has informed the Exchange about Credit Rating | Download

Neuland Laboratories Limited has informed the Exchange about Credit Rating | Download

Trading Window-XBRL 
Announced OnMar 27, 2024

NEULAND LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window | Download

NEULAND LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window | Download

Cash Dividend 
Ex. DateJul 11, 2023

Final • Div/Share: ₹ 10

See all events